← Back to Search

Personalized Diet for Rectosigmoid Cancer

N/A

Waitlist Available

Led By Virginia Sun, PhD, RN

Research Sponsored by City of Hope Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 months

Awards & highlights

Study Summary

This trial looks at how well a personalized diet can help manage bowel issues and improve quality of life for people who have rectosigmoid cancer.

Who is the study for?

This trial is for English-speaking stage I-III rectosigmoid cancer survivors who are at least 6 months post-treatment. Participants must be able to sign consent and have either a permanent ostomy or anastomosis. Those with stage IV disease or unable to follow safety requirements can't join.Check my eligibility

What is being tested?

The study tests personalized dietary interventions aimed at managing bowel dysfunction and improving quality of life in rectosigmoid cancer survivors. It involves understanding bowel symptoms, identifying food triggers, adjusting diets, and coaching on healthy eating post-cancer treatment.See study design

What are the potential side effects?

Since this trial focuses on dietary changes rather than medication, side effects may include discomfort from adjusting diet habits but are not expected to involve typical drug-related adverse reactions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability assessed by semi-structured interview

Bowel function assessed by Memorial Sloan Kettering Cancer Center Bowel Function Tool

Feasibility assessed by patient enrollment

+1 more

Other outcome measures

Scores from the Decisional Conflict Scale

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive Care (personalized dietary intervention)Experimental Treatment5 Interventions

At 6 months after standard of care treatment, patients receive 10 sessions of personalized dietary intervention over 30 minutes each over 4 months via the telephone. Patients also receive a workbook including reference materials and intervention content.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Telephone-Based Intervention

2017

Completed Phase 2

~3400

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,657 Previous Clinical Trials

40,933,657 Total Patients Enrolled

70 Trials studying Cancer Survivors

17,541 Patients Enrolled for Cancer Survivors

Hope FoundationOTHER

3 Previous Clinical Trials

314 Total Patients Enrolled

City of Hope Medical CenterLead Sponsor

565 Previous Clinical Trials

1,921,450 Total Patients Enrolled

15 Trials studying Cancer Survivors

3,891 Patients Enrolled for Cancer Survivors

Media Library

Personalized Dietary Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03063918 — N/A

Cancer Survivors Research Study Groups: Supportive Care (personalized dietary intervention)

Cancer Survivors Clinical Trial 2023: Personalized Dietary Intervention Highlights & Side Effects. Trial Name: NCT03063918 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still able to sign up for the experiment?

"The clinical trial's details posted on the official website suggest that it is no longer looking for participants. Initially published in April 2017 and last revised in February 2022, this particular research project has stopped recruiting patients; however, there are 158 other trials taking applications at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

2017. "Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03063918.